Higher doses of buprenorphine may improve treatment outcomes for people with opioid use disorder

Vaping among younger adults and binge drinking among mid-life adults also maintained historically high levels, NIH-supported study shows [] [View as webpage / Share](%2F%2Fcontent.govdelivery.com%2Faccounts%2FUSNIHNIDA%2Fbulletins%2F3b7c1b3/1/0100019229c995ca-fbe68e30-d946-4063-918e-132a04805bc2-000000/cCBlib_gyYon_coabmYiLaVV9rsaSAxQTo4RdDxaBt8=372) [NIH/NIDA logo] NEWS [Man sitting outside and thoughtfully looking across a quiet lake during a clear sunny day.] Higher doses of buprenorphine may improve treatment outcomes for people with opioid use disorder Adults with opioid use disorder who receive a higher daily dose of the opioid addiction treatment medication buprenorphine may have a lower risk of subsequent emergency department visits or use of inpatient services related to behavioral health (such as for mental health and substance use disorders) than adults receiving the recommended dose, according to an analysis funded by the National Institutes of Health (NIH). These findings suggest that higher buprenorphine doses could be more effective in managing opioid use disorder, which may be particularly relevant for improving treatment for those who use fentanyl, a major driver of the overdose crisis. [View Press Release](%2F%2Fnida.nih.gov%2Fnews-events%2Fnews-releases%2F2024%2F09%2Fhigher-doses-of-buprenorphine-may-improve-treatment-outcomes-for-people-with-opioid-use-disorder/1/0100019229c995ca-fbe68e30-d946-4063-918e-132a04805bc2-000000/R06Fjk160rPM3IIj2JODplVbQa5SbF3xnc97LxtUnpI=372) Stay Connected [facebook](%2F%2Fwww.facebook.com%2FNIDANIH/1/0100019229c995ca-fbe68e30-d946-4063-918e-132a04805bc2-000000/KrHOv4MdItvuD98cMymGVHIBPhd405PNkZTEAEVIDJs=372)[X](%2F%2Fx.com%2FNIDAnews/1/0100019229c995ca-fbe68e30-d946-4063-918e-132a04805bc2-000000/q8J20aszhnLgYD8qi5pdf_GgUIjy5YSGUWZBz3yiOZU=372)[linkedin](%2F%2Fwww.linkedin.com%2Fcompany%2Fthe-national-institute-on-drug-abuse-nida/1/0100019229c995ca-fbe68e30-d946-4063-918e-132a04805bc2-000000/dvsyrU_NhTLK0XNko-YIMB2OVKUR42meHWFAFnrzG0Q=372)[youtube](%2F%2Fwww.youtube.com%2Fuser%2FNIDANIH/1/0100019229c995ca-fbe68e30-d946-4063-918e-132a04805bc2-000000/1dNnJHP5LsvWMDFOUIzXucEW3oAnX84zVdKb8Gutu5Q=372) --------------------------------------------------------------- View topics of interest, update your subscriptions, modify your password or email address, alter frequency of bulletins, or stop subscriptions at any time on your [Subscriber Preferences Page](%2F%2Fpublic.govdelivery.com%2Faccounts%2FUSNIHNIDA%2Fsubscriber%2Fnew%3Fpreferences=true/1/0100019229c995ca-fbe68e30-d946-4063-918e-132a04805bc2-000000/s9p2MVcXK7MmFEkdasLFBN5ZyFxGizFRCQpBAFyxW7M=372). You will need to use your email address to log in. If you have questions or problems with the subscription service, please visit [subscriberhelp.govdelivery.com](%2F%2Fsubscriberhelp.govdelivery.com%2F/1/0100019229c995ca-fbe68e30-d946-4063-918e-132a04805bc2-000000/iPOtDOZchH3HAPnX_GQ5MoOSvBKbZ4eRY80WOYORz9g=372). This service is provided to you at no charge by [National Institute on Drug Abuse](%2F%2Fnida.nih.gov%2F/1/0100019229c995ca-fbe68e30-d946-4063-918e-132a04805bc2-000000/A05Ez1xh-BqBhBdofgP7sZbP-MNNaqTQIxPbxGkXO_M=372). --------------------------------------------------------------- This email was sent to {EMAIL} using govDelivery Communications Cloud on behalf of National Institutes of Health: National Institute on Drug Abuse · 3WFN MSC 6024 · 16071 Industrial Dr ·Dock 11 · Gaithersburg, MD 20877 [GovDelivery logo](%2F%2Fsubscriberhelp.granicus.com%2F/1/0100019229c995ca-fbe68e30-d946-4063-918e-132a04805bc2-000000/croPysKPnJBRlfIhZFDIuXPjuGTVX5DMk30V-27bbN4=372)